News & Updates

Show Multimedia Only

Continuous use of TNFi on the rise in pregnant women

A trend toward increased continuous use of tumour necrosis factor inhibitors has been observed throughout gestation, which suggests growing confidence in the safety and effectiveness of this medication during pregnancy, reveals a study.

Continuous use of TNFi on the rise in pregnant women

14 hours ago

Transition model eases move from paediatric to adult care for cSLE patients

16 hours ago by

A recent study has demonstrated the effectiveness of a structured paediatric-adult dyad transition care model in encouraging prompt initial attendance and ensuring continuity of care for patients with childhood-onset systemic lupus erythematosus (cSLE) during the critical transition from paediatric to adult healthcare.

Transition model eases move from paediatric to adult care for cSLE patients

16 hours ago

ICONIC-LEAD affirms oral icotrokinra benefits in plaque psoriasis

17 hours ago by

In the phase III ICONIC-LEAD trial, selective blockade of the interleukin(IL)-23 receptor with the targeted oral peptide icotrokinra is associated with higher rates of skin clearance and symptom relief in adults and adolescents with moderate-to-severe plaque psoriasis.

ICONIC-LEAD affirms oral icotrokinra benefits in plaque psoriasis

17 hours ago

Antimicrobial use rises following TNFi initiation in PsA patients

a day ago

A recent study has noted a temporary increase in antimicrobial use following initiation of tumour necrosis factor inhibitor (TNFi) treatment, with no significant risk in serious infections, among patients with psoriatic arthritis (PsA).

Antimicrobial use rises following TNFi initiation in PsA patients

a day ago

Nipocalimab shows promise in Sjögren's disease

07 Dec 2025

Treatment with nipocalimab is safe and helps improve clinical disease activity in patients with moderate-to-severe, active Sjögren's disease, according to the phase II DAHLIAS trial.

Nipocalimab shows promise in Sjögren's disease

07 Dec 2025

Is PT good for knee OA?

04 Dec 2025 by

Contrary to routine recommendations, physical therapy (PT) does not appear to benefit individuals with knee pain due to degenerative meniscal tear, findings from the TeMPO* trial suggest.

Is PT good for knee OA?

04 Dec 2025

Colchicine may lower risk of arthroplasty in gout patients

02 Dec 2025

Among patients with gout, colchicine users appear to have a modestly reduced risk of total joint arthroplasty, as shown in a study.

Colchicine may lower risk of arthroplasty in gout patients

02 Dec 2025

Telitacicept beneficial in childhood-onset SLE

14 Nov 2025

In the management of patients with childhood-onset systemic lupus erythematosus (cSLE), combining telitacicept with standard of care (SoC) appears to reduce disease activity, steroid exposure, and immunological marker concentrations, effects comparable to those observed with belimumab, according to a study.